作者: Angela D. M. Kashuba , Joseph S. Bertino
DOI: 10.1385/1-59259-924-9:013
关键词:
摘要: One hundred and fifty million outpatient prescriptions for antibiotics are dispensed each year in the United States (1). In institutional settings, 25–35% of hospitalized patients receive antibiotic treatment active infections or to prevent (2). Given that represent global sales approximately $20 billion a $370 pharmaceutical market, one can assume many who prescribed also receiving other agents (3). Therefore, potential drug interactions is significant.